Cite
HARVARD Citation
Foley, J. et al. (2022). 136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS. Journal of neurology, neurosurgery and psychiatry. 93 (9), pp. e2-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Foley, J. et al. (2022). 136 NOVA primary results randomised controlled study of natalizumab Q6W versus continued Q4W treatment for MS. Journal of neurology, neurosurgery and psychiatry. 93 (9), pp. e2-. [Online].